Cancer Research · 2005 · 249 citations · 25 references
MedicineCancer BiologyOncologyCarcinogenesisMolecular OncologyTumor ProgressionGrowth Factor SignalingMammary Epithelial Cell BiologyMammary Gland DevelopmentMammary TumorsOncogenic Signaling PathwaysOncogenic VirusesGrowth FactorsMammary Gland Development GeneticsMammary Gland MorphogenesisMammary GlandsMetastatic Breast Cancer BiologyTransgenic Mouse Cancer ModelsTumor Promoter MechanismsTumor Suppressor Pathways
Transforming growth factor-beta (TGF-beta) isoforms are growth factors that function physiologically to regulate development, cellular proliferation, and immune responses. The role of TGF-beta signaling in mammary tumorigenesis is complex, as TGF-beta has been reported to function as both a tumor suppressor and tumor promoter. To elucidate the role of TGF-beta signaling in mammary gland development, tumorigenesis, and metastasis, the gene encoding type II TGF-beta receptor, Tgfbr2, was conditionally deleted in the mammary epithelium (Tgfbr2MGKO). Loss of Tgfbr2 in the mammary epithelium results in lobular-alveolar hyperplasia in the developing mammary gland and increased apoptosis. Tgfbr2MGKO mice were mated to the mouse mammary tumor virus-polyomavirus middle T antigen (PyVmT) transgenic mouse model of metastatic breast cancer. Loss of Tgfbr2 in the context of PyVmT expression results in a shortened median tumor latency and an increased formation of pulmonary metastases. Thus, our studies support a tumor-suppressive role for epithelial TGF-beta signaling in mammary gland tumorigenesis and show that pulmonary metastases can occur and are even enhanced in the absence of TGF-beta signaling in the carcinoma cells.
25